List of redirects
Jump to navigation
Jump to search
Showing below up to 50 results in range #1 to #50.
View (previous 50 | next 50) (20 | 50 | 100 | 250 | 500)
- 5-FU → Fluorouracil (5-FU)
- 5-fluorouracil → Fluorouracil (5-FU)
- 5FU → Fluorouracil (5-FU)
- ABT-199 (GDC-0199) → Venetoclax (Venclexta)
- AG-120 → Ivosidenib (AG-120)
- AG-221 → Enasidenib (Idhifa)
- AHUS → Atypical hemolytic uremic syndrome
- AIHA → Autoimmune hemolytic anemia
- ALCL → Anaplastic large cell lymphoma
- ALL → Category:Acute lymphoblastic leukemias
- ARN-509 → Apalutamide (ARN-509)
- ASPS → Alveolar soft part sarcoma
- ATLL → Adult T-cell leukemia-lymphoma
- AZD5363 → Capivasertib (AZD5363)
- Abemaciclib (LY2835219) → Abemaciclib (Verzenio)
- Abiraterone → Abiraterone (Zytiga)
- Abraxane → Paclitaxel, nanoparticle albumin-bound (Abraxane)
- Acalabrutinib (ACP-196) → Acalabrutinib (Calquence)
- Aclarubicin (Aclacinomycin) → Aclarubicin (Aclacinon)
- Acquired coagulopathy → Acquired hemophilia A
- Actinium-225 (225Ac)-Lintuzumab (Actimab-A) → Actinium Ac 225 lintuzumab (Actimab-A)
- Acute lymphocytic leukemia → B-cell acute lymphoblastic leukemia
- Acute myeloblastic leukemia → Acute myeloid leukemia
- Acute myelogenous leukemia → Acute myeloid leukemia
- Acute myeloid leukaemia → Acute myeloid leukemia
- Acute myeloid leukaemia, FLT3-positive → Acute myeloid leukemia, FLT3-positive
- Acute myeloid leukaemia, IDH-mutated → Acute myeloid leukemia, IDH-mutated
- Acute myeloid leukemia, FLTE3-positive - null regimens → Acute myeloid leukemia, FLT3-positive - null regimens
- Acute promyelocytic leukaemia → Acute promyelocytic leukemia
- Adagrasib (MRTX849) → Adagrasib (Krazati)
- Adenocarcinoma of unknown primary → Carcinoma of unknown primary
- Ado-trastuzumab emtansine (Kadcyla) → Trastuzumab emtansine (Kadcyla)
- Adult T-cell leukaemia-lymphoma → Adult T-cell leukemia-lymphoma
- Afatinib (BIBW 2992) → Afatinib (Gilotrif)
- Afatinib (Gliotrif) → Afatinib (Gilotrif)
- Aflibercept (Zaltrap) → Ziv-aflibercept (Zaltrap)
- Afuresertib → Afuresertib (GSK2110183)
- Aml → Acute myeloid leukemia
- Anal carcinoma → Anal cancer
- Andexanet alfa (PRT4445) → Andexanet alfa (Andexxa)
- Anlotinib (AL-3818) → Anlotinib (Fukewei)
- Antidepressants → Antidepressants and other psychiatric medications in cancer care
- Antithrombin III (Thrombate III) → Antithrombin III (human and recombinant)
- Apalutamide (ARN-509) → Apalutamide (Erleada)
- Apatinib (YN968D1) → Apatinib (Aitan)
- Apl → Acute promyelocytic leukemia
- Apml → Acute promyelocytic leukemia
- Ara-C → Cytarabine (Ara-C)
- Argatroban → Argatroban (Acova)
- Asciminib (ABL001) → Asciminib (Scemblix)